Risk-adapted melphalan (MEL) with stem cell transplant (SCT) and adjuvant dexamethasone (D)+/- thalidomide (T) for AL patients achieves low treatment-related mortality (TRM) and high hematologic response rates Meeting Abstract
| Authors: | Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L. |
| Abstract Title: | Risk-adapted melphalan (MEL) with stem cell transplant (SCT) and adjuvant dexamethasone (D)+/- thalidomide (T) for AL patients achieves low treatment-related mortality (TRM) and high hematologic response rates |
| Meeting Title: | 11th International Symposium on Amyloidosis |
| Journal Title: | Amyloid |
| Volume: | 13 |
| Issue: | Suppl.1 |
| Meeting Dates: | 2006 Nov 5-9 |
| Meeting Location: | Woods Hole, MA |
| ISSN: | 1350-6129 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2006-01-01 |
| Start Page: | 23 |
| Language: | English |
| ACCESSION: | WOS:000242411900050 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract - 11th International Symposium on Amyloidosis - NOV 05-09, 2006 - Woods Hole, MA - "1" - "Source: Wos" |
